Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Jul 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.2M
Net Open-Market Flow
-$5.2M
Transactions
10
9 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)10K$135.42$1.3M50K
Jul 9, 2026Sell(S)440$548.16$241K50K
Jul 9, 2026Sell(S)2K$549.01$843K48K
Jul 9, 2026Sell(S)1K$550.12$799K47K
Jul 9, 2026Sell(S)3K$551.03$1.6M44K
Jul 9, 2026Sell(S)2K$552.38$910K42K
Jul 9, 2026Sell(S)801$553.29$443K41K
Jul 9, 2026Sell(S)640$554.23$355K41K
Jul 9, 2026Sell(S)120$555.76$67K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)10K$030K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000095) within minutes of acceptance. Every field above traces to the original document. Verify it directly: